For a stock that had been struggling for significance for much of the past year, this dramatic shift was not merely a rally — ...

SPARC Kips Bay will provide modern facilities for 4,500 City University of New York students and create a clear pathway to ...

The developer behind Philadelphia's largest life sciences building says the market needs patience after venture capital ...

Cassava Sciences ( ($SAVA) ) has provided an update. Between August 27 and October 26, 2021, four putative federal securities class actions were ...

Austin-based Cassava Sciences has reached a settlement agreement in a years-long investor lawsuit that centered on ...

As of Friday, December 19, Cassava Sciences, Inc.’s SAVA share price has dipped by 17.37%, which has investors questioning if this is right time to buy.

Gilead Sciences said its in-development HIV treatment met the primary endpoint of a recent late-stage clinical trial. The biopharmaceutical company said Monday that the treatment, a once-daily single ...

Bamman’s project bridges large-scale computational analysis in AI with humanistic scholarship in film and television.

Duquesne University officials say a new, $68 million health sciences facility will locate clinical services, consolidate programs and strengthen the college’s role in regional health care. Duquesne ...

Gilead Sciences, Inc. (Nasdaq: GILD) announced today that Keeley Wettan will be appointed Executive Vice President, General ...

Partnerships with giants like Eli Lilly and Thermo Fisher Scientific put biotech in the spotlight again, though founders still struggle to find investments in their hometown.